FDA’s Contradictory Decisions Related to the Delaney Clause

DSpace/Manakin Repository

dc.contributor.advisor	Peter Hutt	en_US
dc.contributor.author	Klimko, Katheryn
dc.date.accessioned	2012-07-06T20:11:28Z
dc.date.issued	2011
dc.identifier.citation	Katheryn Klimko, FDA’s Contradictory Decisions Related to the Delaney Clause (May 2011).	en_US
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8963872
dc.description.abstract	This paper will focus on FDA regulation under the Delaney Clause, and particularly regulations that have led to contradictory results. It first will examine the history and basic requirements of the Delaney Clause. It next will discuss cancer: statistics regarding the frequency, types, and causes of cancer. Then it will examine some foods and food additives that have been associated with some level of carcinogenicity and how FDA has handled them. It will conclude by discussing the inherent problems that the Delaney Clause presents in establishing a uniform system of regulation and, finally, by proposing some potential alternative ways in which FDA might better use its power to help the public avoid excessive exposure to carcinogenic food substances.	en_US
dash.license	LAA
dc.subject.other	Food and Drug Law	en_US
dc.title	FDA’s Contradictory Decisions Related to the Delaney Clause	en_US
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-07-06T20:11:28Z